Quest Diagnostics Reports First Quarter 2016 Financial Results

Go back to Quest Diagnostics Reports First Quarter 2016 Financial Results

Mizuho Securities Raises Price Target on Quest Diagnostics (DGX) Following In-Line 1Q Results

April 21, 2016 2:16 PM EDT

Mizuho Securities reiterated an Outperform rating on Quest Diagnostics (NYSE: DGX), and raised the price target to $84.00 (from $75.00), following the company's 1Q earnings report. DGX reported an adjusted EPS of $1.12, in-line with consensus estimates.

Analyst Ann Hynes commented, "We are raising our price... More

Quest Diagnostics (DGX) Reports In-Line Q1 EPS; Reaffirms Outlook

April 21, 2016 6:47 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q1 EPS of $1.12, in-line with the analyst estimate of $1.12. Revenue for the quarter came in at $1.86 billion versus the consensus estimate of $1.82 billion.

"We're off to a good start in 2016 with a solid performance in the first... More